Paragard MDL Case Count History: Steady Growth Before Bellwether Trials

The recent federal count line

JPML’s July 1, 2024 report listed 2,736 pending actions in Paragard MDL 2974 and 2,822 total historical actions. On January 2, 2025, those columns read 2,882 and 3,077. The 146-action net increase in pending inventory was smaller than the 255-action increase in historical inventory, indicating that actions entered and left active status during the six-month interval.

By April 1, 2026, the docket had reached 3,982 pending and 4,276 historical actions. The July 1, 2026 report listed 4,111 pending and 4,409 historical. That last quarter added a net 129 pending actions and 133 historical actions. The figures are exact for those four reporting dates; they do not justify fabricated monthly points or an assumption that growth was linear between snapshots.

What JPML’s two columns mean here

“Actions Now Pending” is the active federal inventory attributed to the MDL on a specified day. “Total Actions (Historical)” is cumulative. By July 2026, the 298-action difference represented matters that had entered the MDL’s history but were no longer pending. The report does not say whether they were dismissed, remanded, transferred, consolidated, resolved, or changed status for another reason.

Neither column is a medical denominator. The total does not represent all Paragard users, all reports of breakage, or all people who underwent fragment retrieval. It also does not necessarily include state-court-only litigation or unfiled concerns. Comparing an FDA adverse-event total to an MDL case count would mix separate systems with different inclusion rules and reporting limitations.

Why growth is not proof of device defect or causation

The centralized actions generally share allegations that a Paragard device broke during removal and that warnings were inadequate. Defendants dispute liability. Centralization lets one judge coordinate common discovery and motion practice; it does not certify a class or decide that the device was defective. More complaints mean more federal actions were active, not that the allegations were adjudicated.

An individual history still turns on product identity, insertion and removal records, the circumstances of the break, imaging, retained-fragment evidence, later procedures, claimed injury, warning evidence, timing, and state law. FDA labeling says breakage of an embedded device during non-surgical removal has been reported, but that statement is not a general incidence rate and does not establish the mechanism or legal cause in one patient.

Bellwether scheduling does not change the arithmetic

The Northern District of Georgia has used fact sheets, case-specific discovery, and a bellwether process to prepare selected cases for trial. A bellwether is intended to test evidence and recurring issues in a manageable set of cases. Selection does not mean a plaintiff has won, and a scheduled trial can be postponed, resolved, or narrowed by later orders.

A rising docket ahead of bellwethers may increase administrative pressure, but it does not produce a reliable settlement forecast. Parties evaluate far more than volume, including expert rulings, product and injury patterns, legal defences, trial outcomes, and documentation quality. No arithmetic operation on 4,111 pending actions yields an average payment, a participation rate, or a date when the MDL will end.

How to keep future Paragard updates accurate

Each update should cite a dated JPML PDF and state pending and historical totals together. If the count falls, report a net decline without calling it a settlement unless the court record says so. If it rises, avoid saying the increase proves a safety conclusion. The practice-and-procedure orders page is the better source for bellwether selection, deadlines imposed on parties, dismissals, and trial scheduling.

As of July 1, 2026, the narrow, supportable conclusion is that MDL 2974 continued to grow, reaching 4,111 pending and 4,409 historical actions. The official materials reviewed do not supply a universal claimant deadline, public payout matrix, completed global settlement, or courtwide finding of defect. Readers should verify any later trial date against the current court page because scheduling orders can change.

Reader questions

Frequently asked questions